Yahya F Jamous
Overview
Explore the profile of Yahya F Jamous including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jamal Q, Ansari M, Alharbi A, Alomary M, Jamous Y, Dutta T, et al.
J Mol Graph Model
. 2025 Feb;
136:108976.
PMID: 39961277
Ebola virus (EBOV) is a negative-strand RNA virus that causes hemorrhagic fever and fatal illness in humans. According to WHO, the Ebola virus caused 28,646 fatal cases and 11,323 deaths...
2.
Abdullah S, Altwaijry N, Alnakhli M, ALenezi G, Al-Masud A, Henidi H, et al.
PLoS One
. 2025 Jan;
20(1):e0314941.
PMID: 39821171
Methotrexate (MTX) is classified as an antimetabolite. It's commonly used to treat lung cancer. MTX is an immunosuppressant following the above-mentioned mechanism of action due to its poor selectivity. The...
3.
Jamous Y, Alghamdi B, Jarrar Y, Hindi E, Alam M, Abd El-Aziz G, et al.
Pharmaceuticals (Basel)
. 2024 Nov;
17(11).
PMID: 39598366
Etoricoxib is a widely used anti-inflammatory drug, but its safety profile concerning cardiovascular and renal health remains inadequately explored. This study aimed to assess the nephro- and cardiotoxic effects of...
4.
Alguraini J, Saleem M, Mahrous N, Shamsan A, Zaidi F, Alhumaidan O, et al.
Infect Dis Rep
. 2024 Aug;
16(4):770-782.
PMID: 39195010
Objective: This cross-sectional-survey-based study aimed to investigate the severity of side-effects from Coronavirus disease (COVID-19) mRNA (Pfizer, Moderna), viral vector DNA (Oxford-AstraZeneca, J&J/Janssen), inactivated virus (Sinopharm, Sinovac), and other vaccines...
5.
Sultana S, Ashwini B, Ansari M, Alomary M, Jamous Y, Ravikiran T, et al.
Bioprocess Biosyst Eng
. 2024 Mar;
47(8):1259-1269.
PMID: 38526617
This study emphasized on the synthesis of zinc oxide nanoparticles (ZnO NPs) in an environmentally friendly manner from the extract of Catharanthus roseus leaves and its antibacterial assessment against the...
6.
Jarrar Y, Ashour W, Madani A, Jarrar Q, Abulebdah D, Jamous Y, et al.
J Basic Clin Physiol Pharmacol
. 2024 Mar;
35(1-2):85-91.
PMID: 38468541
Objectives: The principal motive of this study is to explore the influence maternal separation (MS) exhibits on the mRNA expression of major drug metabolizing-cyp450s in parallel with the assessment of...
7.
Mahrous N, Jamous Y, Almatrafi A, Fallatah D, Theyab A, Alanati B, et al.
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893135
Alport syndrome (AS) is a rare genetic disorder categorized by the progressive loss of kidney function, sensorineural hearing loss and eye abnormalities. It occurs due to mutations in three genes...
8.
Jamous Y, Alhomoud D
Cureus
. 2023 Oct;
15(9):e45602.
PMID: 37868494
The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in numerous deaths worldwide, along with devastating economic disruptions, and has...
9.
Abdullah S, Bani-Jaber A, Alhakamy N, Jamous Y, Al-Masud A, Marzoog Al-Sharafa M
Eur J Pharm Biopharm
. 2023 Aug;
191:78-89.
PMID: 37619955
The goal of the study was to look into drug-polyelectrolyte complexation between ciprofloxacin (Cipro) and λ-carrageenan (CRG), and to employ the complex as a sustained-release matrix. The maximum binding capacity...
10.
Nelson V, Nuli M, Mastanaiah J, Saleem T S M, Birudala G, Jamous Y, et al.
Front Endocrinol (Lausanne)
. 2023 Aug;
14:1201198.
PMID: 37560308
Colorectal cancer (CRC) is one of the most deaths causing diseases worldwide. Several risk factors including hormones like insulin and insulin like growth factors (e.g., IGF-1) have been considered responsible...